Total Payments
$4,692
2022 Payments
$74.52
Companies
18
Transactions
187
Medicare Patients
197
Medicare Billing
$34,463
Payment Breakdown by Category
Food & Beverage$3,219 (68.6%)
Travel$1,468 (31.3%)
Education$4.55 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,219 | 183 | 68.6% |
| Travel and Lodging | $1,468 | 3 | 31.3% |
| Education | $4.55 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Research & Development, LLC | $2,142 | 22 | $0 (2018) |
| Allergan, Inc. | $620.14 | 44 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $604.32 | 49 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $489.10 | 30 | $0 (2022) |
| Lundbeck LLC | $123.86 | 7 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $120.99 | 7 | $0 (2021) |
| Orexo US, Inc. | $99.99 | 1 | $0 (2017) |
| ABBVIE INC. | $95.18 | 6 | $0 (2022) |
| Shire North American Group Inc | $85.55 | 5 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $63.72 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $74.52 | 5 | Janssen Pharmaceuticals, Inc ($48.23) |
| 2021 | $247.24 | 14 | AbbVie Inc. ($68.89) |
| 2020 | $181.81 | 11 | Allergan, Inc. ($112.34) |
| 2019 | $593.17 | 41 | Sunovion Pharmaceuticals Inc. ($151.30) |
| 2018 | $1,504 | 55 | Janssen Research & Development, LLC ($847.26) |
| 2017 | $2,091 | 61 | Janssen Research & Development, LLC ($1,295) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Neuroscience | ||||||
| 05/31/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Neuroscience | ||||||
| 02/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Neuroscience | ||||||
| 01/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: CNS | ||||||
| 10/18/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Central Nervous System | ||||||
| 10/13/2021 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $11.34 | General |
| Category: PSYCHIATRY | ||||||
| 10/12/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Neuroscience | ||||||
| 08/05/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: CNS | ||||||
| 06/30/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: NEUROSCIENCE | ||||||
| 06/02/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: NEUROLOGY | ||||||
| 05/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: PSYCHIATRY | ||||||
| 02/16/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: PSYCHIATRY | ||||||
| 02/04/2021 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: PSYCHIATRY | ||||||
| 01/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Neuroscience | ||||||
| 12/01/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2020 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 13 | $3,733 | $1,727 |
| 2022 | 2 | 33 | 144 | $24,411 | $7,758 |
| 2021 | 3 | 84 | 226 | $35,391 | $11,055 |
| 2020 | 2 | 67 | 277 | $46,372 | $13,923 |
Total Patients
197
Total Services
660
Medicare Billing
$34,463
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,733 | $1,727 | 46.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 114 | $19,038 | $6,221 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 30 | $5,373 | $1,537 | 28.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 35 | 135 | $22,545 | $7,528 | 33.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 54 | $9,072 | $2,853 | 31.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 21 | 37 | $3,774 | $673.75 | 17.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 34 | 164 | $27,388 | $9,415 | 34.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 113 | $18,984 | $4,508 | 23.7% |
About Dr. Mark Townsend, MD
Dr. Mark Townsend, MD is a Psychiatry healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497778351.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Townsend, MD has received a total of $4,692 in payments from pharmaceutical and medical device companies, with $74.52 received in 2022. These payments were reported across 187 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,219).
As a Medicare-enrolled provider, Townsend has provided services to 197 Medicare beneficiaries, totaling 660 services with total Medicare billing of $34,463. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Austin, TX
- Active Since 07/25/2006
- Last Updated 05/25/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1497778351
Products in Payments
- VRAYLAR (Drug) $715.32
- LATUDA (Drug) $604.32
- INVEGA SUSTENNA (Drug) $397.29
- ABILIFY MAINTENA (Drug) $139.07
- Zubsolv (Drug) $99.99
- REXULTI (Drug) $94.44
- SPRAVATO (Drug) $75.37
- AUSTEDO (Drug) $63.72
- INVEGA TRINZA (Drug) $61.89
- Fanapt (Drug) $46.80
- ARISTADA (Drug) $45.04
- MYDAYIS (Drug) $43.06
- VYVANSE (Drug) $42.49
- INGREZZA (Drug) $28.14
- BELSOMRA (Drug) $27.82
- Trintellix (Drug) $24.69
- Aristada 441 mg (Drug) $12.62
- CAPLYTA (Drug) $11.83
- BRINTELLIX (Drug) $11.34
- INVEGA (Drug) $4.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Austin
Dr. Donald Garcia, Md, MD
Psychiatry — Payments: $4.0M
Psychiatry $4.0M
Dr. Arvinder Pal Walia, M.d, M.D
Psychiatry — Payments: $2.7M
Psychiatry $2.7M
Charles Nemeroff, Md Phd, MD PHD
Psychiatry — Payments: $400,808
Psychiatry $400,808
Dr. Divyansu Patel, M.d, M.D
Psychiatry — Payments: $319,461
Psychiatry $319,461
Frank Floca, Md, MD
Psychiatry — Payments: $99,177
Psychiatry $99,177
Dr. Charles Sweet, M.d., M.p.h, M.D., M.P.H
Psychiatry — Payments: $88,371
Psychiatry $88,371